Skip to main content
OpenTrials
Completed

NCT Number: NCT07510763

Piriformis and Gluteal Muscle Thickness in Patients With Unilateral Greater Trochanteric Pain Syndrome

This study aims to evaluate muscle thickness in patients with unilateral Greater Trochanteric Pain Syndrome using ultrasonography and to compare these findings with healthy individuals. The primary objective is to determine whether piriformis muscle thickness differs between patients and controls. Secondary objectives include assessing gluteus medius and gluteus maximus muscle thickness, side-to-side differences in piriformis and gluteal muscle thickness, and the presence of Deep Gluteal Syndrome.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ankara Etlik City Hospital

Ankara, 06170, Turkey (Türkiye)

About this study

This observational cross-sectional study investigates ultrasonographic muscle morphology and associated clinical findings in patients with unilateral Greater Trochanteric Pain Syndrome (GTPS), focusing on piriformis and gluteal muscle thickness, symptom severity, and Deep Gluteal Syndrome-related findings.

Participants with unilateral GTPS and healthy controls are recruited from outpatient clinical settings. The clinical diagnosis of Greater Trochanteric Pain Syndrome is based on the presence of lateral hip pain in combination with at least two of the following findings: tenderness over the greater trochanter on palpation, pain during a 30-second single-leg stance test, or supportive ultrasonographic findings.

Ultrasonographic evaluations are performed bilaterally to measure piriformis, gluteus medius, and gluteus maximus muscle thickness. For each muscle, three measurements are obtained, and the mean value is used for analysis. Inter-side differences between affected and unaffected hips in the GTPS group and between both hips in the control group are calculated to assess asymmetry.

In the control group, the mean values of both hips are calculated and used as reference values. Comparisons are performed between affected and unaffected hips within the patient group. In addition, muscle thickness of the affected and unaffected hips in the GTPS group is compared separately with the control group mean values for each muscle. Inter-side differences in muscle thickness are also compared between patients and healthy controls. Trochanteric bursal fluid and Doppler signal changes are also evaluated using ultrasonography.

The presence of Deep Gluteal Syndrome is determined based on clinical criteria, defined as at least one clinical finding together with at least two positive standardized clinical provocation tests. Patients are categorized as Deep Gluteal Syndrome-positive or negative accordingly.

Symptom severity is assessed using the VISA-G (Victorian Institute of Sport Assessment-Gluteal) questionnaire. Correlation analyses are performed to evaluate the association between VISA-G scores and inter-side differences in muscle thickness.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults aged 18 years or older
  • Diagnosis of unilateral Greater Trochanteric Pain Syndrome

Exclusion criteria

  • Presence of lumbar radiculopathy
  • Presence of hip or spinal osteoarthritis
  • History of lumbar spine or lower extremity surgery
  • Presence of neurological disorders affecting muscles or peripheral nerves
  • Pregnancy
  • Presence of cognitive impairment or neuropsychiatric conditions limiting participation
  • Unwillingness to participate
  • Regular participation in physical exercise (defined as more than two sessions per week)

Treatment and study plan

Primary outcomes

  1. Piriformis Muscle Thickness

    Time frame: At baseline

    Comparison of piriformis muscle thickness between patients with unilateral Greater Trochanteric Pain Syndrome and healthy controls using ultrasonography

Secondary outcomes

  1. Gluteus Medius and Gluteus Maximus Muscle Thickness

    Time frame: At baseline

    Comparison of gluteus medius and gluteus maximus muscle thickness between patients with unilateral Greater Trochanteric Pain Syndrome and healthy controls using ultrasonography.

  2. Side-to-Side Muscle Thickness Comparison

    Time frame: At baseline

    Within-group comparison of piriformis, gluteus medius, and gluteus maximus muscle thickness between affected and unaffected sides in patients with unilateral Greater Trochanteric Pain Syndrome.

  3. Trochanteric Bursa and Doppler Findings

    Time frame: At baseline

    Assessment of trochanteric bursal fluid and Doppler signal changes in patients with Greater Trochanteric Pain Syndrome using ultrasonography.

  4. Prevalence of Deep Gluteal Syndrome

    Time frame: At baseline

    Assessment of the presence of Deep Gluteal Syndrome in patients with Greater Trochanteric Pain Syndrome based on clinical evaluation and standardized provocation tests.

  5. Correlation Between VISA-G Score and Hip Muscle Thickness Asymmetry

    Time frame: At baseline

    Correlation between VISA-G score and inter-side muscle thickness differences of piriformis, gluteus medius, and gluteus maximus measured by ultrasonography in the patient group.

  6. Inter-side difference in muscle thickness between patients and controls

    Time frame: At baseline

    Comparison of inter-side differences in piriformis, gluteus medius, and gluteus maximus muscle thickness between patients with unilateral Greater Trochanteric Pain Syndrome and healthy controls using ultrasonography

Sponsors and collaborators

Lead sponsor

Ankara Etlik City Hospital

Other Gov

Registry information

Official study title

Observational Assessment of Deep Gluteal Syndrome and Bilateral Piriformis, Gluteus Medius, and Gluteus Maximus Muscle Thickness Using Ultrasonography in Patients With Unilateral Greater Trochanteric Pain Syndrome

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Apr 3, 2026
Registry last updated
Apr 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.